Trastuzumab Biosimilar Market Share

Geographically, the trastuzumab biosimilar market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Europe industry is estimated to account for largest revenue share by 2036, owing to increasing prevalence of breast cancer, strong clinical pipeline, increasing research and drug development activities propels market growth in the region. Furthermore, in 2021, the market in Asia Pacific is evaluated to occupy the largest share in terms of revenue, Asia Pacific is a promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors to the growth of this market. Emerging and huge population base countries such as China and India offer tremendous trastuzumab biosimilar market opportunities due to investments for trastumuzab biosimilar research. As per the analysis of World Health Organization, cancer accounts for 20% of deaths in the European Region.